{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:37:12Z","timestamp":1785253032589,"version":"3.55.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clim.2025.110643","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T23:40:35Z","timestamp":1763854835000},"page":"110643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The dual role of the COX-2\/PGE2 Axis in multiple sclerosis: From pathogenesis to pharmacological inhibition"],"prefix":"10.1016","volume":"283","author":[{"given":"Ahmed Salem","family":"Al-Dhahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawar R.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubarak","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda J.","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2025.110643_bb0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/15548627.2023.2259281","article-title":"The beneficial role of autophagy in multiple sclerosis: yes or no?","volume":"20","author":"Al-kuraishy","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.clim.2025.110643_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejpn.2021.06.002","article-title":"Immunization in multiple sclerosis and other childhood immune-mediated disorders of the central nervous system: a review of the literature","volume":"33","author":"Solmaz","year":"2021","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.clim.2025.110643_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.70067","article-title":"The possible role of metformin and fibroblast growth Factor-21 in multiple sclerosis neuropathology: birds of a feather flock together","volume":"61","author":"Abulaban","year":"2025","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102816","article-title":"Clinical features of late-onset multiple sclerosis: a systematic review and Meta-analysis","volume":"50","author":"Naseri","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.clim.2025.110643_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70167","article-title":"The compelling role of brain-derived neurotrophic factor signaling in multiple sclerosis: role of BDNF activators","volume":"30","author":"Al-kuraishy","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.clim.2025.110643_bb0030","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","article-title":"Secondary progressive multiple sclerosis: new insights","volume":"97","author":"Cree","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2025.110643_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/npr2.70039","article-title":"Primary progressive multiple sclerosis: new therapeutic approaches","volume":"45","author":"Rajabi","year":"2025","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.clim.2025.110643_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111333","article-title":"Role of liver X receptor in multiple sclerosis: a long furtive life behind a barrier","volume":"224","author":"Abulaban","year":"2025","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.clim.2025.110643_bb0045","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.2025.1604","article-title":"High-dose vitamin D in clinically isolated syndrome typical of multiple sclerosis the D-lay MS randomized clinical trial","volume":"333","author":"Thouvenot","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2025.110643_bb0050","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/13524585241245306","article-title":"Radiologically isolated syndrome in the spectrum of multiple sclerosis","volume":"30","author":"Okuda","year":"2024","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.clim.2025.110643_bb0055","article-title":"Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment","volume":"103","author":"Haki","year":"2024","journal-title":"Medicine (United States)"},{"key":"10.1016\/j.clim.2025.110643_bb0060","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10787-023-01240-x","article-title":"The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects","volume":"31","author":"Al-Kuraishy","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.clim.2025.110643_bb0065","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1007\/s11064-023-03981-1","article-title":"Pathogenic role of fibrinogen in the neuropathology of multiple sclerosis: a tale of sorrows and fears","volume":"48","author":"Alruwaili","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.clim.2025.110643_bb0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40001-024-01700-2","article-title":"Role of fenofibrate in multiple sclerosis","volume":"29","author":"Abulaban","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.clim.2025.110643_bb0075","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156254","article-title":"Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis","volume":"132","author":"Asashima","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.clim.2025.110643_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00726-021-03111-7","article-title":"Multiple sclerosis and myelin basic protein: insights into protein disorder and disease","volume":"54","author":"Martinsen","year":"2022","journal-title":"Amino Acids"},{"key":"10.1016\/j.clim.2025.110643_bb0085","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/ijms24010894","article-title":"Myelin basic protein in oligodendrocyte-derived extracellular vesicles as a diagnostic and prognostic biomarker in multiple sclerosis: a pilot study","volume":"24","author":"Agliardi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2025.110643_bb0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1515\/tnsci-2020-0169","article-title":"Hormones in experimental autoimmune encephalomyelitis (EAE) animal models","volume":"12","author":"Ghareghani","year":"2021","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1019877","article-title":"Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis","volume":"15","author":"Melamed","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","article-title":"Blood\u2013brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies","volume":"23","author":"Zierfuss","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2025.110643_bb0105","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.3390\/ijms22189753","article-title":"Synaptic dysfunction in multiple sclerosis: a red thread from inflammation to network disconnection","volume":"22","author":"Bellingacci","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2025.110643_bb0110","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.3390\/ijms22168370","article-title":"Reviewing the significance of blood\u2013brain barrier disruption in multiple sclerosis pathology and treatment","volume":"22","author":"Balasa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2025.110643_bb0115","first-page":"117","article-title":"Quantification of blood-brain-barrier permeability dysregulation and inflammatory activity in MS lesions by dynamic-contrast enhanced MR imaging, basic","volume":"13","author":"Oghabian","year":"2022","journal-title":"Clin. Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0120","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.3390\/ijms24076373","article-title":"Mechanisms of demyelination and Remyelination strategies for multiple sclerosis","volume":"24","author":"Zhao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2025.110643_bb0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41582-023-00801-6","article-title":"Inflammation in multiple sclerosis: consequences for remyelination and disease progression","volume":"19","author":"Klotz","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.clim.2025.110643_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13041-024-01077-7","article-title":"The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology","volume":"17","author":"Amoriello","year":"2024","journal-title":"Mol. Brain"},{"key":"10.1016\/j.clim.2025.110643_bb0135","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.neuron.2022.09.023","article-title":"CNS remyelination and inflammation: from basic mechanisms to therapeutic opportunities","volume":"110","author":"Franklin","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.clim.2025.110643_bb0140","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/stem.3374","article-title":"Multifaceted involvement of microglia in gray matter pathology in multiple sclerosis","volume":"39","author":"Tsouki","year":"2021","journal-title":"Stem Cells"},{"key":"10.1016\/j.clim.2025.110643_bb0145","article-title":"Neurodegeneration in multiple sclerosis","volume":"15","author":"Mey","year":"2023","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.clim.2025.110643_bb0150","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ana.20179","article-title":"PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis","volume":"56","author":"Bilak","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2025.110643_bb0155","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1471-4159.2011.07363.x","article-title":"The cyclooxygenase-2 pathway via the PGE 2 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelination","volume":"121","author":"Palumbo","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.clim.2025.110643_bb0160","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tips.2013.05.003","article-title":"Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection","volume":"34","author":"Jiang","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.clim.2025.110643_bb0165","first-page":"111","article-title":"Pathogenesis and progression of multiple sclerosis: the role of arachidonic acid-mediated neuroinflammation","author":"Palumbo","year":"2017","journal-title":"Multiple Sclerosis: Perspect. Treatment Pathogenesis"},{"key":"10.1016\/j.clim.2025.110643_bb0170","article-title":"Expression analysis of p50-associated COX-2 extragenic RNA and NF-kappa B interacting long non-coding RNA in multiple sclerosis patients","volume":"2","author":"Shirvani-Farsani","year":"2023","journal-title":"J. Pharmaceut. Biomed. Anal. Open"},{"key":"10.1016\/j.clim.2025.110643_bb0175","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/brain\/awl170","article-title":"Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway","volume":"129","author":"Miyamoto","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.clim.2025.110643_bb0180","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1471-4159.2011.07363.x","article-title":"The cyclooxygenase-2 pathway via the PGE 2 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelination","volume":"121","author":"Palumbo","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.clim.2025.110643_bb0185","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.apsb.2022.01.002","article-title":"Recent development on COX-2 inhibitors as promising anti-inflammatory agents: the past 10 years","volume":"12","author":"Ju","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.clim.2025.110643_bb0190","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1080\/02648725.2022.2122290","article-title":"Prostaglandins and non-steroidal anti-inflammatory drugs in Covid-19","volume":"40","author":"Al-Kuraishy","year":"2024","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.clim.2025.110643_bb0195","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/pcn.12092","article-title":"Positive and negative effects of prostaglandins in Alzheimer\u2019s disease","volume":"68","author":"Fattahi","year":"2014","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0200","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clim.2025.110643_bb0205","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2174\/0113894501323980240815113851","article-title":"Prostaglandins in the inflamed central nervous system: potential therapeutic targets","volume":"25","author":"Sheremeta","year":"2024","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.clim.2025.110643_bb0210","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1038\/s41598-021-83438-z","article-title":"Three-dimensional structure of human cyclooxygenase (hCOX)-1","volume":"11","author":"Miciaccia","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2025.110643_bb0215","first-page":"2058","article-title":"Network pharmacology integrated molecular docking and dynamics to elucidate saffron compounds targeting human COX-2 protein","volume":"59","author":"Ali","year":"2023","journal-title":"Medicina (Lithuania)"},{"key":"10.1016\/j.clim.2025.110643_bb0220","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10426","article-title":"Different chemical structures and physiological\/pathological roles of cyclooxygenases","volume":"12","author":"Faki","year":"2021","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.clim.2025.110643_bb0225","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.3390\/molecules26103036","article-title":"Antiplatelet activity of coumarins: in vitro assays on cox-1","volume":"26","author":"Zaragoz\u00e1","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.clim.2025.110643_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105926","article-title":"Celecoxib paradoxically induces COX-2 expression and astrocyte activation through the ERK\/JNK\/AP-1 signaling pathway in the cerebral cortex of rats","volume":"183","author":"Wei","year":"2025","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.clim.2025.110643_bb0235","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1111\/ejn.16165","article-title":"The crucial role that hippocampus Cyclooxygenase-2 plays in memory","volume":"58","author":"Ni","year":"2023","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s10194-025-02116-x","article-title":"Substrate-selective COX-2 inhibition by IMMA attenuates posttraumatic headache via endocannabinoid modulation and neuroinflammatory suppression","volume":"26","author":"Wen","year":"2025","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.clim.2025.110643_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114143","article-title":"Effect of selective cyclooxygenase inhibitors on animal behaviour and monoaminergic systems of the rat brain","volume":"438","author":"Napora","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.clim.2025.110643_bb0250","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s12035-021-02706-1","article-title":"COX-2\/PGE2 pathway inhibits the Ferroptosis induced by cerebral ischemia reperfusion","volume":"59","author":"Xu","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.clim.2025.110643_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114729","article-title":"Deciphering the mechanisms of regulation of an excitatory synapse via cyclooxygenase-2. A review","volume":"192","author":"Stachowicz","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.clim.2025.110643_bb0260","first-page":"10","article-title":"Prostaglandins: key players in immunomodulation of the nervous system","author":"Wang","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.clim.2025.110643_bb0265","first-page":"206","article-title":"The role of CREB and CBP in brain function, transcription factors in the nervous system: development","author":"Barco","year":"2006","journal-title":"Brain Funct. Dis."},{"key":"10.1016\/j.clim.2025.110643_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00089","article-title":"Protective effects of L-902,688, a prostanoid EP4 receptor agonist, against acute blood-brain barrier damage in experimental ischemic stroke","volume":"12","author":"DeMars","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0275","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","article-title":"Blood-brain barrier tight junction permeability and ischemic stroke","volume":"32","author":"Sandoval","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.clim.2025.110643_bb0280","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s11064-016-2168-6","article-title":"Prostaglandin E2 EP4 receptor activation attenuates Neuroinflammation and early brain injury induced by subarachnoid hemorrhage in rats","volume":"42","author":"Xu","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.clim.2025.110643_bb0285","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1523\/JNEUROSCI.0410-14.2014","article-title":"Suppression of Alzheimer-associated inflammation by microglial prostaglandin-E2 EP4 receptor signaling","volume":"34","author":"Woodling","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0290","doi-asserted-by":"crossref","first-page":"9692","DOI":"10.1074\/jbc.M709663200","article-title":"Prostaglandin E receptor type 4-associated protein interacts directly with NF-\u03baB1 and attenuates macrophage activation","volume":"283","author":"Minami","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2025.110643_bb0295","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3897\/rrpharmacology.7.70974","article-title":"Neuroprotective and cerebrovascular effects of endogenous N-Arachidonoyl-GABA and its putative Cox-2 metabolite \u2013 GABA conjugate with prostaglandin E2","volume":"7","author":"Mirzoyan","year":"2021","journal-title":"Res. Results Pharmacol."},{"key":"10.1016\/j.clim.2025.110643_bb0300","doi-asserted-by":"crossref","DOI":"10.2174\/0113894501383329250616070727","article-title":"The role of PGE2 in age-related diseases","author":"Guan","year":"2025","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.clim.2025.110643_bb0305","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/cns.13228","article-title":"Role of the PGE2 receptor subtypes EP1, EP2, and EP3 in repetitive traumatic brain injury","volume":"26","author":"Catlin","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.clim.2025.110643_bb0310","doi-asserted-by":"crossref","first-page":"14850","DOI":"10.1523\/JNEUROSCI.3922-11.2011","article-title":"Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus","volume":"31","author":"Serrano","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0315","doi-asserted-by":"crossref","first-page":"10742","DOI":"10.1074\/jbc.R112.411645","article-title":"Calcium channels and short-term synaptic plasticity","volume":"288","author":"Catterall","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2025.110643_bb0320","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neulet.2011.12.010","article-title":"Prostaglandin E2 receptor 1 activity regulates cell survival following hypoxia in cultured rat cortical neurons","volume":"508","author":"Liu","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.clim.2025.110643_bb0325","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10571-015-0287-2","article-title":"EP3, Prostaglandin E2 receptor subtype 3, associated with neuronal apoptosis following intracerebral hemorrhage","volume":"36","author":"Ni","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.clim.2025.110643_bb0330","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1471-4159.2011.07363.x","article-title":"The cyclooxygenase-2 pathway via the PGE 2 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelination","volume":"121","author":"Palumbo","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.clim.2025.110643_bb0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1742-2094-7-25","article-title":"Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death","volume":"7","author":"Carlson","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2025.110643_bb0340","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/glia.23212","article-title":"Reactive astrocyte COX2-PGE2 production inhibits oligodendrocyte maturation in neonatal white matter injury","volume":"65","author":"Shiow","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.clim.2025.110643_bb0345","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jneuroim.2003.12.021","article-title":"Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion","volume":"149","author":"Rose","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2025.110643_bb0350","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2006.12.012","article-title":"Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury","volume":"184","author":"Ahmad","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2025.110643_bb0355","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1073\/pnas.0604400103","article-title":"Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury","volume":"103","author":"Ikeda-Matsuo","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2025.110643_bb0360","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3839\/jabc.2022.053","article-title":"Comparative analysis of active components and antioxidant activities of Brussels sprouts (Brassica oleracea var. gemmifera) and cabbage (Brassica oleracea var. capitata)","volume":"65","author":"Jeon","year":"2022","journal-title":"J. Appl. Biol. Chem."},{"key":"10.1016\/j.clim.2025.110643_bb0365","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/FJC.0b013e3182244a12","article-title":"Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases","volume":"59","author":"Tang","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.clim.2025.110643_bb0370","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1523\/JNEUROSCI.4485-03.2004","article-title":"Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia","volume":"24","author":"McCullough","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0375","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tips.2013.05.003","article-title":"Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection","volume":"34","author":"Jiang","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.clim.2025.110643_bb0380","doi-asserted-by":"crossref","DOI":"10.1186\/s12868-015-0182-2","article-title":"Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor","volume":"16","author":"Leclerc","year":"2015","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0385","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12640-013-9410-7","article-title":"Role of PGE2 EP1 receptor in intracerebral hemorrhage-induced brain injury","volume":"24","author":"Singh","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.clim.2025.110643_bb0390","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02297-7","article-title":"Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer\u2019s disease","volume":"18","author":"Banik","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2025.110643_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1575022","article-title":"Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation","volume":"19","author":"M\u00fcller","year":"2025","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0400","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1124\/pr.112.007195","article-title":"The prostanoid EP4 receptor and its signaling pathway","volume":"65","author":"Yokoyama","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.clim.2025.110643_bb0405","first-page":"1089","article-title":"The effects of voluntary swimming on iNOS and COX-2 protein contents as well as memory and motor performance in Cuprizone-induced multiple sclerosis rats model","volume":"41","author":"Marashi","year":"2024","journal-title":"J. Isfahan Med. School"},{"key":"10.1016\/j.clim.2025.110643_bb0410","doi-asserted-by":"crossref","first-page":"P5","DOI":"10.1212\/WNL.86.16_supplement.P5.335","article-title":"Thromboxane A2 levels are increased in the CSF of active multiple sclerosis patients (P5.335)","volume":"86","author":"Mir","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2025.110643_bb0415","doi-asserted-by":"crossref","first-page":"21807","DOI":"10.1073\/pnas.0906891106","article-title":"Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis","volume":"106","author":"Kihara","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2025.110643_bb0420","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/946813","article-title":"Role of prostaglandins in neuroinflammatory and neurodegenerative diseases","volume":"2012","author":"Lima","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.clim.2025.110643_bb0425","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clim.2025.110643_bb0430","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.335","article-title":"Prostacyclin promotes oligodendrocyte precursor recruitment and remyelination after spinal cord demyelination","volume":"4","author":"Takahashi","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.clim.2025.110643_bb0435","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2174\/0113894501323980240815113851","article-title":"Prostaglandins in the inflamed central nervous system: potential therapeutic targets","volume":"25","author":"Sheremeta","year":"2024","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.clim.2025.110643_bb0440","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4899-0200-9_17","article-title":"PGI2 and its analogs: from pharmacology to therapeutic applications","author":"Nicosia","year":"1996","journal-title":"Eicosanoids"},{"key":"10.1016\/j.clim.2025.110643_bb0445","first-page":"414","article-title":"Prostaglandin E2-induced inflammation: relevance of prostaglandin e receptors","volume":"2015","author":"Kawahara","year":"1851","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.clim.2025.110643_bb0450","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9087816","article-title":"The signaling pathway of PGE2and its regulatory role in T cell differentiation","volume":"2021","author":"An","year":"2021","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.clim.2025.110643_bb0455","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1742-2094-7-25","article-title":"Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death","volume":"7","author":"Carlson","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2025.110643_bb0460","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1742-2094-7-25","article-title":"Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death","volume":"7","author":"Carlson","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2025.110643_bb0465","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jneuroim.2006.01.008","article-title":"The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis","volume":"174","author":"Carlson","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2025.110643_bb0470","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12974-015-0323-7","article-title":"The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to death","volume":"12","author":"Carlson","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2025.110643_bb0475","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1523\/JNEUROSCI.21-20-08198.2001","article-title":"Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice","volume":"21","author":"Andreasson","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clim.2025.110643_bb0480","article-title":"Expression analysis of p50-associated COX-2 extragenic RNA and NF-kappa B interacting long non-coding RNA in multiple sclerosis patients","volume":"2","author":"Shirvani-Farsani","year":"2023","journal-title":"J. Pharmaceut. Biomed. Anal. Open"},{"key":"10.1016\/j.clim.2025.110643_bb0485","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11010-016-2770-6","article-title":"The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients","volume":"420","author":"Morel","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.clim.2025.110643_bb0490","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1177\/1352458513475833","article-title":"High risk of cardiovascular diseases after diagnosis of multiple sclerosis","volume":"19","author":"Jadidi","year":"2013","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.clim.2025.110643_bb0495","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000320245","article-title":"Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study","volume":"35","author":"Christiansen","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.clim.2025.110643_bb0500","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.plefa.2013.08.008","article-title":"Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: role of cyclooxygenase-2","volume":"89","author":"Palumbo","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.clim.2025.110643_bb0505","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/1871527319666200825164123","article-title":"A systematic review on the role of arachidonic acid pathway in multiple sclerosis","volume":"21","author":"Hoxha","year":"2020","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.clim.2025.110643_bb0510","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1039\/D1MD00280E","article-title":"Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors","volume":"13","author":"Ahmadi","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.clim.2025.110643_bb0515","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.3390\/jcm10132835","article-title":"Anti-inflammatory drugs in patients with ischemic heart disease","volume":"10","author":"Pello L\u00e1zaro","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.clim.2025.110643_bb0520","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/bmj.329.7471.867","article-title":"Lessons from the withdrawal of rofecoxib","volume":"329","author":"Dieppe","year":"2004","journal-title":"Br. Med. J."},{"key":"10.1016\/j.clim.2025.110643_bb0525","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.2174\/0929867327999200917150939","article-title":"Natural COX-2 inhibitors as promising anti-inflammatory agents: An update","volume":"28","author":"Cui","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.clim.2025.110643_bb0530","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2147\/JIR.S282128","article-title":"Celecoxib exerts a therapeutic effect against demyelination by improving the immune and inflammatory microenvironments","volume":"13","author":"Cao","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.clim.2025.110643_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083119","article-title":"A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation","volume":"8","author":"Di Penta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2025.110643_bb0540","first-page":"391","article-title":"Doxycycline and meloxicam can treat neuroinflammation by increasing activity of antioxidant enzymes in rat brain","volume":"32","author":"Dik","year":"2019","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.clim.2025.110643_bb0545","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neulet.2012.05.045","article-title":"Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson\u2019s disease model","volume":"521","author":"Tasaki","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.clim.2025.110643_bb0550","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4103\/1673-5374.295339","article-title":"Co-nanoencapsulated meloxicam and curcumin improves cognitive impairment induced by amyloid-beta through modulation of cyclooxygenase-2 in mice","volume":"16","author":"Eduarda","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.clim.2025.110643_bb0555","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1073\/pnas.98.3.1294","article-title":"Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice","volume":"98","author":"Iadecola","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2025.110643_bb0560","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10875-006-8787-y","article-title":"COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis","volume":"26","author":"Muthian","year":"2006","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110643_bb0565","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2007.03.012","article-title":"COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-\u03b3 and IL-10 production by inhibiting T-bet expression","volume":"186","author":"Ni","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2025.110643_bb0570","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12974-023-02981-w","article-title":"Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?","volume":"21","author":"Broos","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2025.110643_bb0575","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.plefa.2014.08.004","article-title":"Prostaglandin F2\u03b1 FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model","volume":"91","author":"Iwasa","year":"2014","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.clim.2025.110643_bb0580","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.it.2023.01.004","article-title":"Harnessing prostaglandin E2 signaling to ameliorate autoimmunity","volume":"44","author":"Burkett","year":"2023","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2025.110643_bb0585","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pneurobio.2017.10.007","article-title":"The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: clues for other neuroinflammatory diseases","volume":"160","author":"Chiurchi\u00f9","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.clim.2025.110643_bb0590","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1007\/s11033-022-07223-5","article-title":"Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis","volume":"49","author":"Khan","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.clim.2025.110643_bb0595","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.expneurol.2010.03.030","article-title":"The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis","volume":"224","author":"Rossi","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.clim.2025.110643_bb0600","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tips.2014.03.001","article-title":"COX-2-derived endocannabinoid metabolites as novel inflammatory mediators","volume":"35","author":"Alhouayek","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.clim.2025.110643_bb0605","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.3390\/molecules26113389","article-title":"Therapeutic attributes of endocannabinoid system against neuro-inflammatory autoimmune disorders","volume":"26","author":"Ahmed","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.clim.2025.110643_bb0610","doi-asserted-by":"crossref","DOI":"10.3390\/nu15132978","article-title":"The role of vitamin D in neuroprotection in multiple sclerosis: An update","volume":"15","author":"Sangha","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clim.2025.110643_bb0615","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neulet.2017.05.050","article-title":"The expression of VDR mRNA but not NF-\u03baB surprisingly decreased after vitamin D treatment in multiple sclerosis patients","volume":"653","author":"Shirvani-Farsani","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.clim.2025.110643_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145488","article-title":"Vitamin D changes expression of DNA repair genes in the patients with multiple sclerosis","volume":"781","author":"Amirinejad","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.clim.2025.110643_bb0625","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1471-4159.2011.07363.x","article-title":"The cyclooxygenase-2 pathway via the PGE\u2082 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelination","volume":"121","author":"Palumbo","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.clim.2025.110643_bb0630","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.plefa.2013.08.008","article-title":"Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: role of cyclooxygenase-2","volume":"89","author":"Palumbo","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.clim.2025.110643_bb0635","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/glia.23212","article-title":"Reactive astrocyte COX2-PGE2 production inhibits oligodendrocyte maturation in neonatal white matter injury","volume":"65","author":"Shiow","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.clim.2025.110643_bb0640","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2006.12.012","article-title":"Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury","volume":"184","author":"Ahmad","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2025.110643_bb0645","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12974-015-0323-7","article-title":"The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to death","volume":"12","author":"Carlson","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2025.110643_bb0650","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.335","article-title":"Prostacyclin promotes oligodendrocyte precursor recruitment and remyelination after spinal cord demyelination","volume":"4","author":"Takahashi","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.clim.2025.110643_bb0655","series-title":"PGI2 and its Analogs: From Pharmacology to Therapeutic Applications, in: Eicosanoids","first-page":"183","author":"Nicosia","year":"1996"},{"key":"10.1016\/j.clim.2025.110643_bb0660","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/brain\/awl170","article-title":"Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway","volume":"129","author":"Miyamoto","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.clim.2025.110643_bb0665","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10875-006-8787-y","article-title":"COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis","volume":"26","author":"Muthian","year":"2006","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110643_bb0670","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2007.03.012","article-title":"COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-\u03b3 and IL-10 production by inhibiting T-bet expression","volume":"186","author":"Ni","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2025.110643_bb0675","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2147\/JIR.S282128","article-title":"Celecoxib exerts a therapeutic effect against demyelination by improving the immune and inflammatory microenvironments","volume":"13","author":"Cao","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.clim.2025.110643_bb0680","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neulet.2012.05.045","article-title":"Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson\u2019s disease model","volume":"521","author":"Tasaki","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.clim.2025.110643_bb0685","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s10194-025-02116-x","article-title":"Substrate-selective COX-2 inhibition by IMMA attenuates posttraumatic headache via endocannabinoid modulation and neuroinflammatory suppression","volume":"26","author":"Wen","year":"2025","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.clim.2025.110643_bb0690","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tips.2014.03.001","article-title":"COX-2-derived endocannabinoid metabolites as novel inflammatory mediators","volume":"35","author":"Alhouayek","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.clim.2025.110643_bb0695","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.3390\/molecules26113389","article-title":"Therapeutic attributes of endocannabinoid system against neuro-inflammatory autoimmune disorders","volume":"26","author":"Ahmed","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.clim.2025.110643_bb0700","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10875-006-8787-y","article-title":"COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis","volume":"26","author":"Muthian","year":"2006","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110643_bb0705","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pneurobio.2017.10.007","article-title":"The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: clues for other neuroinflammatory diseases","volume":"160","author":"Chiurchi\u00f9","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.clim.2025.110643_bb0710","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1007\/s11033-022-07223-5","article-title":"Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis","volume":"49","author":"Khan","year":"2022","journal-title":"Mol. Biol. Rep."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625002189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625002189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:29:19Z","timestamp":1769128159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661625002189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":142,"alternative-id":["S1521661625002189"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2025.110643","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dual role of the COX-2\/PGE2 Axis in multiple sclerosis: From pathogenesis to pharmacological inhibition","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2025.110643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110643"}}